360 related articles for article (PubMed ID: 16895604)
21. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
22. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Shiraishi T; Alder H; Mimori K; Mori M; Croce CM
Cancer Res; 2002 Apr; 62(8):2258-60. PubMed ID: 11956080
[TBL] [Abstract][Full Text] [Related]
23. Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis.
Kraggerud SM; Aman P; Holm R; Stenwig AE; Fosså SD; Nesland JM; Lothe RA
Cancer Res; 2002 Jan; 62(2):512-7. PubMed ID: 11809703
[TBL] [Abstract][Full Text] [Related]
24. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
25. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
[TBL] [Abstract][Full Text] [Related]
26. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
27. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of the FHIT gene in human prostate cancer.
Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R
Oncogene; 1998 Apr; 16(14):1863-8. PubMed ID: 9583683
[TBL] [Abstract][Full Text] [Related]
29. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
Varella-Garcia M; Gemmill RM; Rabenhorst SH; Lotto A; Drabkin HA; Archer PA; Franklin WA
Cancer Res; 1998 Oct; 58(20):4701-7. PubMed ID: 9788625
[TBL] [Abstract][Full Text] [Related]
30. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
31. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
[TBL] [Abstract][Full Text] [Related]
32. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1.
Krummel KA; Denison SR; Calhoun E; Phillips LA; Smith DI
Genes Chromosomes Cancer; 2002 Jun; 34(2):154-67. PubMed ID: 11979549
[TBL] [Abstract][Full Text] [Related]
33. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T
Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157
[TBL] [Abstract][Full Text] [Related]
35. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
Mao L; Fan YH; Lotan R; Hong WK
Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
[TBL] [Abstract][Full Text] [Related]
36. Induction of the common fragile site FRA3B does not affect FHIT expression.
Michael D; Rajewsky MF
Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927
[TBL] [Abstract][Full Text] [Related]
37. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.
Fang JM; Arlt MF; Burgess AC; Dagenais SL; Beer DG; Glover TW
Genes Chromosomes Cancer; 2001 Mar; 30(3):292-8. PubMed ID: 11170287
[TBL] [Abstract][Full Text] [Related]
38. Evidence that instability within the FRA3B region extends four megabases.
Becker NA; Thorland EC; Denison SR; Phillips LA; Smith DI
Oncogene; 2002 Dec; 21(57):8713-22. PubMed ID: 12483524
[TBL] [Abstract][Full Text] [Related]
39. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
[TBL] [Abstract][Full Text] [Related]
40. Structure and expression of the human FHIT gene in normal and tumor cells.
Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K
Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]